Human cataract mutations in EPHA2 SAM domain alter receptor stability and function.

The cellular and molecular mechanisms underlying the pathogenesis of cataracts leading to visual impairment remain poorly understood. In recent studies, several mutations in the cytoplasmic sterile-α-motif (SAM) domain of human EPHA2 on chromosome 1p36 have been associated with hereditary cataracts...

Full description

Bibliographic Details
Main Authors: Jeong Eun Park, Alexander I Son, Rui Hua, Lianqing Wang, Xue Zhang, Renping Zhou
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3343017?pdf=render
_version_ 1818164281674301440
author Jeong Eun Park
Alexander I Son
Rui Hua
Lianqing Wang
Xue Zhang
Renping Zhou
author_facet Jeong Eun Park
Alexander I Son
Rui Hua
Lianqing Wang
Xue Zhang
Renping Zhou
author_sort Jeong Eun Park
collection DOAJ
description The cellular and molecular mechanisms underlying the pathogenesis of cataracts leading to visual impairment remain poorly understood. In recent studies, several mutations in the cytoplasmic sterile-α-motif (SAM) domain of human EPHA2 on chromosome 1p36 have been associated with hereditary cataracts in several families. Here, we have investigated how these SAM domain mutations affect EPHA2 activity. We showed that the SAM domain mutations dramatically destabilized the EPHA2 protein in a proteasome-dependent pathway, as evidenced by the increase of EPHA2 receptor levels in the presence of the proteasome inhibitor MG132. In addition, the expression of wild-type EPHA2 promoted the migration of the mouse lens epithelial αTN4-1 cells in the absence of ligand stimulation, whereas the mutants exhibited significantly reduced activity. In contrast, stimulation of EPHA2 with its ligand ephrin-A5 eradicates the enhancement of cell migration accompanied by Akt activation. Taken together, our studies suggest that the SAM domain of the EPHA2 protein plays critical roles in enhancing the stability of EPHA2 by modulating the proteasome-dependent process. Furthermore, activation of Akt switches EPHA2 from promoting to inhibiting cell migration upon ephrin-A5 binding. Our results provide the first report of multiple EPHA2 cataract mutations contributing to the destabilization of the receptor and causing the loss of cell migration activity.
first_indexed 2024-12-11T17:02:58Z
format Article
id doaj.art-48a72f288dfd4378873bd86c32b3c242
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-11T17:02:58Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-48a72f288dfd4378873bd86c32b3c2422022-12-22T00:57:47ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0175e3656410.1371/journal.pone.0036564Human cataract mutations in EPHA2 SAM domain alter receptor stability and function.Jeong Eun ParkAlexander I SonRui HuaLianqing WangXue ZhangRenping ZhouThe cellular and molecular mechanisms underlying the pathogenesis of cataracts leading to visual impairment remain poorly understood. In recent studies, several mutations in the cytoplasmic sterile-α-motif (SAM) domain of human EPHA2 on chromosome 1p36 have been associated with hereditary cataracts in several families. Here, we have investigated how these SAM domain mutations affect EPHA2 activity. We showed that the SAM domain mutations dramatically destabilized the EPHA2 protein in a proteasome-dependent pathway, as evidenced by the increase of EPHA2 receptor levels in the presence of the proteasome inhibitor MG132. In addition, the expression of wild-type EPHA2 promoted the migration of the mouse lens epithelial αTN4-1 cells in the absence of ligand stimulation, whereas the mutants exhibited significantly reduced activity. In contrast, stimulation of EPHA2 with its ligand ephrin-A5 eradicates the enhancement of cell migration accompanied by Akt activation. Taken together, our studies suggest that the SAM domain of the EPHA2 protein plays critical roles in enhancing the stability of EPHA2 by modulating the proteasome-dependent process. Furthermore, activation of Akt switches EPHA2 from promoting to inhibiting cell migration upon ephrin-A5 binding. Our results provide the first report of multiple EPHA2 cataract mutations contributing to the destabilization of the receptor and causing the loss of cell migration activity.http://europepmc.org/articles/PMC3343017?pdf=render
spellingShingle Jeong Eun Park
Alexander I Son
Rui Hua
Lianqing Wang
Xue Zhang
Renping Zhou
Human cataract mutations in EPHA2 SAM domain alter receptor stability and function.
PLoS ONE
title Human cataract mutations in EPHA2 SAM domain alter receptor stability and function.
title_full Human cataract mutations in EPHA2 SAM domain alter receptor stability and function.
title_fullStr Human cataract mutations in EPHA2 SAM domain alter receptor stability and function.
title_full_unstemmed Human cataract mutations in EPHA2 SAM domain alter receptor stability and function.
title_short Human cataract mutations in EPHA2 SAM domain alter receptor stability and function.
title_sort human cataract mutations in epha2 sam domain alter receptor stability and function
url http://europepmc.org/articles/PMC3343017?pdf=render
work_keys_str_mv AT jeongeunpark humancataractmutationsinepha2samdomainalterreceptorstabilityandfunction
AT alexanderison humancataractmutationsinepha2samdomainalterreceptorstabilityandfunction
AT ruihua humancataractmutationsinepha2samdomainalterreceptorstabilityandfunction
AT lianqingwang humancataractmutationsinepha2samdomainalterreceptorstabilityandfunction
AT xuezhang humancataractmutationsinepha2samdomainalterreceptorstabilityandfunction
AT renpingzhou humancataractmutationsinepha2samdomainalterreceptorstabilityandfunction